id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-D-0811-0001,FDA,FDA-2013-D-0811,Guidance for Industry; Availability: Enforcement Policy Regarding Investigational New Drug Requirements; Use of Fecal Microbiota for Transplantation to Treat Clostridium difficile Infection Not Responsive to Standard Therapies,Notice,,2013-07-18T04:00:00Z,2013,7,2013-07-18T04:00:00Z,,2013-07-18T14:21:00Z,2013-17223,0,0,090000648136d493
FDA-2013-D-0811-0002,FDA,FDA-2013-D-0811,Guidance for Industry; Enforcement Policy Regarding Investigational New Drug Requirements for Use of Fecal Microbiota for Transplantation to Treat Clostridium difficile Infection Not Responsive to Standard Therapies,Other,Guidance,2013-07-01T04:00:00Z,2013,7,2013-07-01T04:00:00Z,,2024-11-07T22:54:24Z,,1,0,090000648136d20e